Get started
KUROS NKUROS NKUROS N

KUROS N

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

KURN chart


Full chart

KURN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪773.36 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.12 CHF
Net income (FY)
‪−4.29 M‬ CHF
Revenue (FY)
‪75.56 M‬ CHF
Shares float
‪35.82 M‬
Beta (1Y)
1.18

Employees


Employees (FY)
4
Change (1Y)
−1 −20.00%
Revenue / Employee (1Y)
‪18.89 M‬ CHF
Net income / Employee (1Y)
‪−929.00 K‬ CHF

About KUROS N


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher T. Fair
Website
kurosbio.com
Headquarters
Schlieren
Founded
2000
ISIN
CH0325814116
FIGI
BBG000BX18D1
Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals, and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment offers Fibrin-PTH, a drug-biologic combination which promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The Legacy portfolio segment is involved in all other products that do not belong to the group's core business strategy. The company was founded by Didier Cowling in 2000 and is headquartered in Schlieren, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

KURN news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as KURN.

Frequently Asked Questions


The current price of KURN is 21.92 CHF — it has increased by 3.00% in the past 24 hours. Watch KUROS N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange KUROS N stocks are traded under the ticker KURN.
KURN stock has risen by 0.46% compared to the previous week, the month change is a 13.75% rise, over the last year KUROS N has showed a 167.32% increase.
We've gathered analysts' opinions on KUROS N future price: according to them, KURN price has a max estimate of 27.00 CHF and a min estimate of 27.00 CHF. Watch KURN chart and read a more detailed KUROS N stock forecast: see what analysts think of KUROS N and suggest that you do with its stocks.
KURN reached its all-time high on Apr 25, 2007 with the price of 12,561.04 CHF, and its all-time low was 1.12 CHF and was reached on Apr 26, 2023. View more price dynamics on KURN chart.
See other stocks reaching their highest and lowest prices.
KURN stock is 6.07% volatile and has beta coefficient of 1.18. Track KUROS N stock price on the chart and check out the list of the most volatile stocks — is KUROS N there?
Today KUROS N has the market capitalization of ‪814.04 M‬, it has increased by 20.62% over the last week.
Yes, you can track KUROS N financials in yearly and quarterly reports right on TradingView.
KUROS N is going to release the next earnings report on Aug 13, 2025. Keep track of upcoming events with our Earnings Calendar.
KUROS N revenue for the last half-year amounts to ‪43.70 M‬ CHF, despite the estimated figure of ‪45.30 M‬ CHF. In the next half-year revenue is expected to reach ‪53.70 M‬ CHF.
KURN net income for the last half-year is ‪−4.08 M‬ CHF, while the previous report showed ‪−211.00 K‬ CHF of net income which accounts for ‪−1.83 K‬% change. Track more KUROS N financial stats to get the full picture.
No, KURN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 4 employees. See our rating of the largest employees — is KUROS N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KUROS N EBITDA is ‪2.57 M‬ CHF, and current EBITDA margin is 3.40%. See more stats in KUROS N financial statements.
Like other stocks, KURN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KUROS N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KUROS N technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KUROS N stock shows the buy signal. See more of KUROS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.